Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future by Mariko Asaoka, Shipra Gandhi, Takashi Ishikawa, Kazuaki Takabe

Get full text

Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic Hormone Receptor–Positive Breast Cancer by Maithreyi Sarma, Yara Abdou, Ajay Dhakal, Shipra Gandhi

Get full text

Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience by Sabah Alaklabi, Arya Mariam Roy, Kristopher Attwood, Anthony George, Tracey O’Connor, Amy Early, Ellis G. Levine, Shipra Gandhi, Shipra Gandhi

Get full text

Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? by Sabah Alaklabi, Arya Mariam Roy, Lubna N. Chaudhary, Shipra Gandhi

Get full text

PI3Kinase Inhibition in Hormone Receptor-Positive Breast Cancer by Ajay Dhakal, Luna Acharya, Ruth O’Regan, Shipra Gandhi, Carla Falkson

Get full text

Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis by Changchuan Jiang, Stuthi Perimbeti, Lei Deng, Charles L. Shapiro, Shipra Gandhi

Get full text

Neratinib-Induced Duodenal Ulcer: A Case Report by Bahar Moftakhar, Prakash Kharel, Sujan Niraula, Shipra Gandhi, Carla Falkson, Ajay Dhakal

Get full text

Predictors of Complete Pathological Response with Chemoimmunotherapy in Triple-Negative Breast Cancer: A Meta-Analysis by Arya Mariam Roy, Supritha Chintamaneni, Sabah Alaklabi, Hassan Awada, Kristopher Attwood, Shipra Gandhi

Get full text

Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward by Kush Gupta, Shipra Gandhi, Alexander Mebane, III, Angelica Singh, Nivetha Vishnuvardhan, Eshan Patel

Get full text

Opportunities for Antigen Discovery in Metastatic Breast Cancer by Ashwani K. Sood, Michael Nemeth, Michael Nemeth, Jianmin Wang, Yun Wu, Shipra Gandhi

Get full text

47982 Reversing the resistance to chemotherapy in White and Black patients with triple negative breast cancer (TNBC). by Shipra Gandhi, Thaer Khoury, Kristopher Attwood, Song Yao, Christine Ambrosone, Kazuaki Takabe, Pawel Kalinski

Get full text

Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer by Yara Abdou, Medhavi Gupta, Mariko Asaoka, Kristopher Attwood, Opyrchal Mateusz, Shipra Gandhi, Kazuaki Takabe

Get full text

Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap by Malak Alharbi, Malak Alharbi, Arya Mariam Roy, Jayasree Krishnan, Pawel Kalinski, Song Yao, Shipra Gandhi

Get full text

Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer by Shipra Gandhi, Ahmed Elkhanany, Masanori Oshi, Tao Dai, Mateusz Opyrchal, Hemn Mohammadpour, Elizabeth A. Repasky, Kazuaki Takabe

Get full text

Development of a novel BRCAness score that predicts response to PARP inhibitors by Masanori Oshi, Shipra Gandhi, Rongrong Wu, Mariko Asaoka, Li Yan, Akimitsu Yamada, Shinya Yamamoto, Kazutaka Narui, Takashi Chishima, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe

Get full text

320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HE... by Pawel Kalinski, Peter Forsyth, Mateusz Opyrchal, Hung Khong, Amy Early, Brian Czerniecki, Shipra Gandhi, Kamran Ahmed, Kristopher Attwood, Ellis Levine, Tracey O’Connor, Robert Fenstermaker, Dheerendra Prasad, Kazuaki Takabe

490 DiRECT Cohort: An NCORP longitudinal observational trial for disparities in results of immune checkpoint inhibitor treatment between Black and White cancer patients by Song Yao, Shipra Gandhi, Christine B Ambrosone, Warren Davis, Eva Culakova, Guilherme Cantuaria, Lori Sakoda, Igor PuzanovCI, Michelle Janelsins, Thaer Khoury, Elisa Rodriguez, Allison Magnuson, Jennifer M Suga, Rajasree P Chowdry, Lawrence H Kushi, Karen Mustian, Gary R Morrow, Charles Kamen

175 Metastatic triple negative breast cancer has distinct tumor immune landscape by Sarabjot Pabla, Marcia Eisenberg, Shipra Gandhi, Erik Van Roey, Shuang Gao, Shengle Zhang, Shakti Ramkissoon, Mary K Nesline, Maria-Fernanda Senosain, Jeffrey M Conroy, Kyle C Strickland, Heidi Ko, Rebecca A Previs, Taylor J Jensen, Brian Caveney, Eric A Severson, Stephanie B Hastings, Robert Seager

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx by Lauren Williams, Paul K Wallace, Pawel Kalinski, Mateusz Opyrchal, Kathleen M Kokolus, Shipra Gandhi, Kristopher Attwood, Agnieszka Witkiewicz, Hans Minderman, Kah Teong Soh, Melissa J Grimm, Ronald T Slomba, Adrienne Groman, Mary Lynne Tarquini, Orla Maguire, Tracey L O’Connor, Amy P Early, Ellis G Levine

Get full text

UACA locus is associated with breast cancer chemoresistance and survival by Qianqian Zhu, Emily Schultz, Jirong Long, Janise M. Roh, Emily Valice, Cecile A. Laurent, Kelly H. Radimer, Li Yan, Isaac J. Ergas, Warren Davis, Dilrini Ranatunga, Shipra Gandhi, Marilyn L. Kwan, Ping-Ping Bao, Wei Zheng, Xiao-Ou Shu, Christine Ambrosone, Song Yao, Lawrence H. Kushi

Get full text